PRIMARY RESULTS OF RF CATHETER ABLATION FOR AF IN VIETNAM HEART INSTITUTE

PHAM QUOC KHANH, MD, PhD. et al Vietnam Heart Institute

Background - Forms of Atrial Fibrillation

- Clinical type of AF:

+ paroxysmal <7days: self-terminating.

+ persistent > 7 days: require intervention

termination.

+ permanent: refractory to cardioversion or

accepted as final rhythm.

-

Background - Prevalence of AFib

General population-based prevalence

ATRIA study

0.95%

2.5% Olmsted County study

Go AS, et al. JAMA (2001) 285: 2370

Miyasaka Y, et al. Circulation (2006) 114: 119

Prevalence of AFib

Olmsted County study

15.9

15.2

16

14.3

F A h t i

14

13.1

11.7

12

10.2

12.1

11.7

10

8.9

11.1

) s n o

w s n o s r e p f o

7.7

10.3

i l l i

8

9.4

6.7

m

(

5.9

8.4

5.1

6

7.5

6.8

6.1

5.6

4 5.1

2

r e b m u n d e t c e j o r P

0

2000

2005

2010

2025

2030

2035

2040

2045

2050

2015 2020

Year

Miyasaka Y, et al. Circulation (2006) 114: 119

Increased Risk of Cardiovascular Events

Death or hospitalization in individuals with CV event(s) after 20 years

100

Men Women

89

)

%

80

66

60

45

40

27

20

( t n e v e V C e n o t s a e l t A

0

AFib No AFib AFib No AFib

Stewart S, et al. Am J Med (2002) 113: 359

Mortality Associated with AFib

Framingham Heart Study, n=5209

80

)

%

60

( p u - w o

Men AFib+ Women AFib+

l l

40

Men AFib- Women AFib-

20

o f g n i r u d y t i l a t r o M

0

0 1 2 3 4 5 6 7 8 9 10

Follow-up (y)

Benjamin EJ, et al. Circulation (1998) 98: 946

Objectives

1. To evaluate the effect of RF catheter ablation

for the treatment of AF

2. To study the applicability of this method

for the clinical practice in Vietnam

METHODS

• 13 consecutive patients (12 male, 1 female) with AF:

( paroxysmal, persistent)

• Mean age:55,9 8,9 ( 46 – 71 )

• Multi-drug-resistant AF

• Serial MSCT before and 3 months after ablation

• 24-hour Holter and patients questionnaire at 3 months

after procedure

Digitex  2400 Angiograph

EP system

angiograph

Carto system

catheter positions

Ablation LIPV

CartoXPTM vs. CartoMergeTM

CARTO XP:

79 pts.

CARTO Merge:

82 pts.

AF ABLATION APPROACH

• Circumferential

approach (WACA)

(Pappone C et al., Circulation 2000; 102(21):2562-4)

• PV-Isolation

(Haissaguerre M et al., N Engl J Med 1998; 339:659–65)

• Additional lines as

needed.

Follow up

• Fu after 1 month (clinical examination, 24h-Holter-

EKG, QOL)

• In hospital Fu at 3, 6 (clinical examination,

Holter/Monitor, Echo, TEE, QOL; Lung scan and MRI as needed)

results and discussions

 13 patients: + Age : 46 - 71; Average : 55,9  8,9

+ Sex : M: 12 ; F: 1

+ Biochemical test: normal

+ TEE: no thrombus in cardiac chambers.

+ Blood test: Normal.

+ Coronary angiography:

- 3 : CHD

- 10: Normal

ECHOCARDIOGRAPHY

LA (mm)

36,3  4,3

Aotic (mm)

31  2,8

Dd (mm)

48,3  4,4

Ds (mm)

30,5  3,2

EF (%)

66,4  6,9

MSCT of LA

RSPV (mm)

16,5  3,5

RIPV (mm)

25,1  4,2

LSPV (mm)

16,5  3,4

LIPV (mm)

15,1  3,2

Left atrial volume(cm3)

48,5  11

Arrhythmia

• Paroxysmal: n = 12 (92,3 %)

• Persistent: n = 1 ( 7,7%)

Classification of success

• Complete : 0 recurrences, 0 drug:

• Partial:

0 recurrences, + drug

• failure:

+ recurrences, + drug

• Clinical response: complete + partial success

+ Complete: 12/13 ( 92,3%).

+ Failure: 1/13: ( 7,7% )

Meta-analysis of Catheter Ablation Studies (I)

Paroxysma l AF

SHD

Patients

6-month cure 6-months OK

Ablation method

Linear

443

75%

26%

33%

55%

Focal

508

81%

35%

54%

71%

Isolation

2,187

83%

36%

62%

75%

Circumferential (all)

15,455

68%

37%

64%

74%

2,449

65%

37%

59%

72%

Circumferential (LACA, WACA)

11,132

68%

42%

67%

76%

Circumferential (PVAI)

559

51%

49%

75%

87%

Substrate ablation (CFAE)

TOTAL

23,626

61%

55%

63%

75%

Cure (by each author’s criteria) means no further AFib 6 months after the procedure in the absence of AAD. OK means improvement (fewer episodes, no episodes with previously ineffective AAD). SHD indicates structural heart disease.

Fisher JD, et al. PACE (2006) 29: 523

Meta-analysis of Catheter Ablation Studies (II)

Patients

Paroxysma l AFib

SHD

6-month cure 6-months OK

Condition / Type of AFib

No structural HD

1,026

86%

3%

81%

72%

Structural HD

350

29%

100%

74%

79%

Paroxysmal AFib

3,880

100%

23%

64%

73%

3,741

0%

82%

66%

74%

Persistent – Permanent AFib

Cure (by each author’s criteria) means no further AFib 6 months after the procedure in the absence of AAD. OK means improvement (fewer episodes, no episodes with previously ineffective AAD). SHD indicates structural heart disease.

Fisher JD, et al. PACE (2006) 29: 523

Worldwide Survey on Efficacy and Safety of Catheter Ablation for AFib

• Total success rate: 76%

• Of 8745 patients:

–27.3% required 1 procedure

–52.0% asymptomatic without drugs

–23.9% asymptomatic with an AAD within <1 yr

• Highly variable outcome between centres

Cappato R, et al. Circulation (2005) 111: 1100

Results from Pioneering Centres

• Total success rate: 75-88%

Study

Year

Follow-up

Age, y

Tool(s)

End point

Parox, %

SHD, %

AF Free (Off drugs), %

Follow-up, d

2004 41 63 ± 9 100 NA 76 178 Ouyang et al CART O PV Isolation

2004 70 53 ± 8 NA 43 Fluoro 79 210 Haïssaguerre et al PV Isolation

2004 40 55 ± 10 80 13 75 330 Mansour et al CART O PV Isolation

2003 259 54 ± 11 51 21 ICE 87 347 Marrouche et al PV Isolation

2003 40 54 ± 11 100 3 88 365 Oral et al CART O EGM Reduction

2003 589 65 ± 9 69 6 79 861 Pappone et al CART O EGM Reduction

Verma A & Natale A Circulation (2005) 112: 1214

Total 1039 81.0

COMPLICATION RATE (n= 13)

Complications

Rate

Transient ischemic attack

0%

Stroke permanent

0%

Tamonade/ perforation

1 /13 (7,7%)

Severe vascular access complication 0%

Complication rates

Consuming time and fluoroscopy time in procedures

Fluoroscopy

Cosuming time(minutes)

time (minutes)

Patients (n=13) 56,5  18,4

266,6  62,8

Case report

• 61-year-old gentleman

• Smoker but quit several years

ago.

• No hypertension, no diabetes

• Symptomatic paroxysmal AF not responded to Amiodarone (300 mg/day)

• Blood test: Normal (Creatinin: 110 mcmol/L)

• Chest X-ray: Normal cardiac silhouette,

clear lungs

• TTE and TEE: Dd 51 mm; EF 71%, very mild

MR, no thrombus in LA

• Coronary MSCT (12/2006): < 50% narrowing

of proximal RCA

MSCT of LA and PVs LA dimensions are 54 mm x 26 mm x 55 mm (LR x AP x SI, respectively). Estimated LA volume: 41 ml

LSPV: 18,3 mm; LIPV: 17 mm; RSPV: 18,7 mm; RIPV: 18,1 mm

A

PV

PV Antrum Isolation

RAO

LAO

conclusion

1. RF catheter ablation can cure paroxysmal and

persistent AF with high successfull rate

2. Further

training and development of the to needed program are this modality of

electrophysiology improve the availability of treatment for AF in Vietnam.

THANK YOU FOR YOUR ATTENTION